The impact of COVID-19 on participation in Australia's National Bowel Cancer Screening Program by people with severe mental illness: A national data linkage study.

IF 4 2区 医学 Q1 PSYCHIATRY
Claudia Bull, Katrina Spilsbury, David Lawrence, Karinna I Saxby, Steve Kisely
{"title":"The impact of COVID-19 on participation in Australia's National Bowel Cancer Screening Program by people with severe mental illness: A national data linkage study.","authors":"Claudia Bull, Katrina Spilsbury, David Lawrence, Karinna I Saxby, Steve Kisely","doi":"10.1177/00048674251336034","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The impact of COVID-19 on Australia's National Bowel Cancer Screening Program remains unclear, especially for individuals with severe mental illness. These individuals have historically participated in the National Bowel Cancer Screening Program at significantly lower rates than the general population. This study aimed to understand the impact of COVID-19 on participation in Australia's National Bowel Cancer Screening Program among individuals with severe mental illness.</p><p><strong>Methods: </strong>Cohort study using deidentified linked health and National Bowel Cancer Screening Program data. We compared participation in the National Bowel Cancer Screening Program between individuals with and without severe mental illness by examining rates of participation (returning an immunochemical faecal occult blood test), returning a valid immunochemical faecal occult blood test, receiving a positive immunochemical faecal occult blood test result and undergoing a follow-up colonoscopy before (25 January 2018-24 January 2020) and during (25 January 2020-31 July 2021) the COVID-19 pandemic.</p><p><strong>Results: </strong>Overall National Bowel Cancer Screening Program participation fell by 10.3% from pre-COVID to during COVID. Less than one-quarter (23.9%) of people with severe mental illness participated in the National Bowel Cancer Screening Program during the COVID-19 pandemic compared to 30.5% before. People with severe mental illness were less likely to return a valid immunochemical faecal occult blood test and more likely to return a positive immunochemical faecal occult blood test result both before and during the pandemic, compared to the general population. They were also significantly less likely to have a colonoscopy following positive immunochemical faecal occult blood test result (pre-COVID adjusted relative risk = 0.97, 95% confidence interval: 0.94-1.01, vs during COVID adjusted relative risk = 0.87, 95% CI: 0.82-0.91).</p><p><strong>Conclusion: </strong>The pandemic significantly reduced the rate at which all Australians participated in the National Bowel Cancer Screening Program. Disparities between people with severe mental illness and the general population generally improved with the exception of follow-up colonoscopy after positive immunochemical faecal occult blood test result.</p>","PeriodicalId":8589,"journal":{"name":"Australian and New Zealand Journal of Psychiatry","volume":" ","pages":"640-650"},"PeriodicalIF":4.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12181642/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australian and New Zealand Journal of Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00048674251336034","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/28 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The impact of COVID-19 on Australia's National Bowel Cancer Screening Program remains unclear, especially for individuals with severe mental illness. These individuals have historically participated in the National Bowel Cancer Screening Program at significantly lower rates than the general population. This study aimed to understand the impact of COVID-19 on participation in Australia's National Bowel Cancer Screening Program among individuals with severe mental illness.

Methods: Cohort study using deidentified linked health and National Bowel Cancer Screening Program data. We compared participation in the National Bowel Cancer Screening Program between individuals with and without severe mental illness by examining rates of participation (returning an immunochemical faecal occult blood test), returning a valid immunochemical faecal occult blood test, receiving a positive immunochemical faecal occult blood test result and undergoing a follow-up colonoscopy before (25 January 2018-24 January 2020) and during (25 January 2020-31 July 2021) the COVID-19 pandemic.

Results: Overall National Bowel Cancer Screening Program participation fell by 10.3% from pre-COVID to during COVID. Less than one-quarter (23.9%) of people with severe mental illness participated in the National Bowel Cancer Screening Program during the COVID-19 pandemic compared to 30.5% before. People with severe mental illness were less likely to return a valid immunochemical faecal occult blood test and more likely to return a positive immunochemical faecal occult blood test result both before and during the pandemic, compared to the general population. They were also significantly less likely to have a colonoscopy following positive immunochemical faecal occult blood test result (pre-COVID adjusted relative risk = 0.97, 95% confidence interval: 0.94-1.01, vs during COVID adjusted relative risk = 0.87, 95% CI: 0.82-0.91).

Conclusion: The pandemic significantly reduced the rate at which all Australians participated in the National Bowel Cancer Screening Program. Disparities between people with severe mental illness and the general population generally improved with the exception of follow-up colonoscopy after positive immunochemical faecal occult blood test result.

COVID-19对严重精神疾病患者参与澳大利亚国家肠癌筛查计划的影响:一项全国性数据链接研究。
目的:COVID-19对澳大利亚国家肠癌筛查计划的影响尚不清楚,特别是对患有严重精神疾病的个体。这些人参加国家肠癌筛查项目的比例比一般人群要低得多。本研究旨在了解COVID-19对严重精神疾病患者参加澳大利亚国家肠癌筛查计划的影响。方法:使用未确定的相关健康和国家肠癌筛查计划数据进行队列研究。在2019冠状病毒病大流行之前(2018年1月25日- 2020年1月24日)和期间(2020年1月25日- 2021年7月31日),通过检查参与(返回免疫化学粪便潜血检查)、返回有效的免疫化学粪便潜血检查、接受免疫化学粪便潜血检查阳性结果和接受后续结肠镜检查的比例,比较了患有和不患有严重精神疾病的个体参与国家肠癌筛查计划的情况。结果:从COVID前到COVID期间,全国肠癌筛查计划的总体参与率下降了10.3%。在COVID-19大流行期间,只有不到四分之一(23.9%)的严重精神疾病患者参加了国家肠癌筛查计划,而之前这一比例为30.5%。与一般人群相比,患有严重精神疾病的人在大流行之前和期间进行有效的免疫化学粪便隐血检查的可能性较小,而在大流行之前和期间进行有效的免疫化学粪便隐血检查的可能性较大。他们在免疫化学粪便隐血检查结果阳性后进行结肠镜检查的可能性也显著降低(COVID前调整相对风险= 0.97,95%置信区间:0.94-1.01,而COVID调整相对风险= 0.87,95% CI: 0.82-0.91)。结论:大流行显著降低了所有澳大利亚人参加国家肠癌筛查计划的比率。严重精神疾病患者与一般人群之间的差异总体上有所改善,但粪便隐血免疫化学试验结果阳性后随访结肠镜检查除外。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
8.00
自引率
2.20%
发文量
149
审稿时长
6-12 weeks
期刊介绍: Australian & New Zealand Journal of Psychiatry is the official Journal of The Royal Australian and New Zealand College of Psychiatrists (RANZCP). The Australian & New Zealand Journal of Psychiatry is a monthly journal publishing original articles which describe research or report opinions of interest to psychiatrists. These contributions may be presented as original research, reviews, perspectives, commentaries and letters to the editor. The Australian & New Zealand Journal of Psychiatry is the leading psychiatry journal of the Asia-Pacific region.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信